Working the Case: Right Middle Lobe BAL, Lymphocyte-Predominant Pattern

Return to the case from the opening. Recovery was 68 mL of 200 mL instilled, 34%, above the 30% adequacy target, and well above the per-aliquot floor that would prompt aborting the procedure. Pooled volume was 68 mL, far more than the 5 mL minimum. Squamous epithelial cells were 2% of the differential, under the 5% contamination flag, and the specimen reached the lab in 30 minutes and was stained and counted the same morning, so degeneration from transport delay is not a concern here. By every adequacy criterion, this specimen supports a confident differential.

With adequacy established, the differential itself becomes evidence worth reading. Alveolar macrophages are 58%, well below the 85% expected in a healthy nonsmoking adult. Lymphocytes are 32%, more than double the 10-15% normal range and above the 15% threshold that defines a lymphocytic pattern. Neutrophils at 6% cross the 3% neutrophilic-pattern threshold, and eosinophils at 2% cross the 1% eosinophilic-pattern threshold, so this differential is technically showing three concurrent pattern shifts, not one. The lymphocyte elevation is by far the largest relative to its own normal ceiling and is reported as the dominant, defining pattern, but the concurrent neutrophilic and eosinophilic shifts are real findings that belong in the report alongside it; a dominant pattern label describes which shift is largest, it does not erase the smaller ones.

No hemosiderin-laden macrophages are identified, and red blood cells are rare and not increasing across aliquots, so there is no supportive evidence for recent alveolar hemorrhage. No organisms and no malignant-appearing cells are seen. None of the escalation triggers described below are present, so this specimen does not require a cytopathology or microbiology referral before a result is released.

The result is released the same day: specimen collected 09:10, received in the lab 09:38, cytospin prepared and stained by 10:05, differential completed and result released by 10:40. No STAT or critical-value pathway is triggered, because organism-seen and malignant-cell-seen findings are the events that typically drive urgent notification in this setting, and neither occurred here.

The lymphocytic pattern itself is reported as a descriptive finding. In the literature, a lymphocyte-predominant BAL differential is a nonspecific pattern associated with entities such as sarcoidosis, hypersensitivity pneumonitis, and drug reaction, among other interstitial lung diseases, but it does not by itself establish any of those diagnoses. BAL cellular analysis alone cannot diagnose a specific interstitial lung disease, with the exception of malignancy and a few rare entities, and a normal differential would not have excluded microscopic disease either. The report states the pattern and lets the clinical team correlate it with imaging and history.

Adequacy first, pattern label second, diagnosis never, at the bench.